Correction to: J Cardiothorac Surg (2019) 14:7
https://doi.org/10.1186/s13019-018-0829-z
The original article [1] contained an error whereby all authors’ names were mistakenly inverted. This error has now been corrected.
Reference
Aravot D, et al. Trimodally treatment for stage IIIa NSCLC patients increases survival while not effecting surgical mortality or complexity. J Cardiothorac Surg. 2019;14:7 https://doi.org/10.1186/s13019-018-0829-z.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
About this article
Cite this article
Aravot, D., Barac, Y.D., Krutzwald-Josefson, E. et al. Correction to: Trimodally treatment for stage IIIa NSCLC patients increases survival while not effecting surgical mortality or complexity. J Cardiothorac Surg 14, 37 (2019). https://doi.org/10.1186/s13019-019-0856-4
Received:
Accepted:
Published:
DOI: https://doi.org/10.1186/s13019-019-0856-4